(4R,12AS)-7-(BENZYLOXY)-N-(2,4-DIFLUOROBENZYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDE
UNII SJ4GZ8739L
Substance Identification & Data
This profile provides standardized clinical and technical data for (4r,12as)-7-(benzyloxy)-n-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SJ4GZ8739L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1206102-11-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H25F2N3O5 RWEIORQEUUWOLH-ZHRRBRCNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4r,12as)-7-(benzyloxy)-n-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.